staceywhite, Author at European Medical Journal - Page 170 of 194

Clinical Trials for the Diagnosis and Management of Stable Ischaemic Heart Disease: Context, Status, and Future Implications

Chest pain and coronary artery disease (CAD) impose a substantial burden on public health and society. Diagnostic imaging tests are used by clinicians to…

EMJ

Paralysed Limb Movement Regained Following Stem Cell Injection

PARALYSIS may no longer be a permanent state for approximately 17,000 new spinal cord injury patients, following the successful experimental treatment of…

EMJ

Yoga and Acupuncture: Alternative Approaches for Chronic Pain Management

COMPLEMENTARY health approaches have been employed in conjunction with standard drug-based therapeutic options to assist in chronic pain management…

EMJ

Targeting Senescent Cells Could Prevent Osteoarthritis

EVIDENCE has been found that cellular senescence, whereby cells stop dividing, causes osteoarthritis (OA), and that targeting these cells may treat or…

EMJ

CHD1 Depletion Sensitises Prostate Cancer Cells to Chemotherapy Drugs

DEPLETING prostate cancer cell lines of a DNA-binding protein makes them hypersensitive to chemotherapeutic drugs, suggesting a possible opening for…

EMJ

Pelvic Floor Disorders: Female Triathletes Running to Incontinence

DEVOTED female triathletes have been identified as having a high rate of pelvic floor disorders.

EMJ

Cell Diversity in Barrett’s Oesophagus Patients Good Predictor of Cancer Risk

The genetic diversity measured between the cells affected by Barrett’s oesophagus has been found to be a good predictor of which patients are at a high…

EMJ

Nanotechnology Applied to Ginger Offers Novel Treatment for Bowel Disease

NANOPARTICLES derived from ginger have been used to produce a beneficial effect in the treatment of inflammatory bowel disease (IBD), offering a novel…

EMJ

Scientists Mobilise Nanorobots to Fight Against Cancer

SWARMS of magneto-aerotactic bacteria equipped with covalently-bound drug-containing nanoliposomes have been administered into the bloodstream to…

EMJ

CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease

INNOVATIVE CRISPR genome editing has been used to inhibit the pathological morphology of red blood cells caused by sickle cell disease, offering a new…